Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool

Table 3 Diagnostic accuracy of SAN

SAN cut point	Accuracy	%	SN	SP	PPV	NPV	LR+	LR-
≥ 0.10	0.66	60.2	0.93	0.54	0.46	0.95	2.02	0.13
≥ 0.20	0.71	48.9	0.84	0.66	0.52	0.90	2.47	0.24
≥ 0.30	0.80	36.6	0.77	0.81	0.63	0.89	4.05	0.28
≥ 0.40	0.81	32.8	0.73	0.85	0.67	0.88	4.87	0.32
≥ 0.50	0.83	24.2	0.62	0.92	0.78	0.85	7.75	0.41
≥ 0.60	0.83	18.8	0.54	0.96	0.86	0.83	13.5	0.48
≥ 0.70	0.84	15.1	0.48	0.99	0.96	0.82	48.0	0.53
≥ 0.80	0.82	12.4	0.41	1.00	1.00	0.80	N/A	0.59
≥ 0.90	0.78	8.1	0.27	1.00	1.00	0.76	N/A	0.73

SAN Screening Algorithm for NASH, SN Sensitivity, SP Specificity, PPV Positive predictive value, NPV Negative predictive value, LR+, positive likelihood ratio; LR-, negative likelihood ratio

ISSN: 2050-7771